AnalystsTara Bancroft
Tara Bancroft's Stock Forecasts

Analyst Ranking
Top 25%
#1371 out of 5511 analysts
Average Return
+35.44%
Win Rate
64%9 out of 14
Risk vs Reward
Poor
Good

Tara Bancroft's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Merus NvMRUS
+148.42%$21.56$53.56
2023-08-21 -
2024-08-21
Buy
Day One Biopharmaceuticals IncDAWN
+103.31%$10.59$21.53
2026-01-13 -
2026-04-23
Strong Buy
Lantheus Holdings IncLNTH
+95.57%$51.74$101.19
2025-09-15 -
2026-08-03
Strong Buy
Harpoon Therapeutics IncHARP
+75.02%$12.81$22.42
2023-11-20 -
2024-01-16
Buy
Protagonist Therapeutics IncPTGX
+62.24%$88.39$143.40
2026-02-26 -
2026-09-15
Strong Buy

Tara Bancroft Analyst Color

Get additional color on Tara Bancroft's coverage of popular stocks

Tara Bancroft's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Faeth Therapeutics IncFTH
1Strong BuyN/AN/AInitiates Coverage On
7 days ago
Eyepoint IncEYPT
1Hold$4.00+9.29%Downgrades
14 days ago
Urogen Pharma LtdURGN
1Strong Buy$60.00+43.75%Maintains
a month ago
Lantheus Holdings IncLNTH
2Hold$102.50+1.76%Downgrades
a month ago
Mineralys Therapeutics IncMLYS
1Strong BuyN/AN/AInitiates Coverage On
5 months ago
Protagonist Therapeutics IncPTGX
2Strong Buy$100.00-30.26%Maintains
7 months ago
Day One Biopharmaceuticals IncDAWN
1Strong Buy$34.00+57.92%Initiates Coverage On
8 months ago
Ocular Therapeutix IncOCUL
4Strong Buy$20.00+96.27%Maintains
a year ago
Tg Therapeutics IncTGTX
1Strong Buy$50.00N/AInitiates Coverage On
2 years ago
Geron CorpGERN
1Strong Buy$10.00N/AInitiates Coverage On
2 years ago
Fusion Pharmaceuticals IncFUSN
1HoldN/AN/ADowngrades
2 years ago
Harpoon Therapeutics IncHARP
2HoldN/AN/ADowngrades
3 years ago
Merus NvMRUS
1BuyN/AN/AInitiates Coverage On
3 years ago
Bicycle Therapeutics PLCBCYC
1BuyN/AN/AInitiates Coverage On
4 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.